Correlation Between Larimar Therapeutics and Century Therapeutics
Can any of the company-specific risk be diversified away by investing in both Larimar Therapeutics and Century Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Larimar Therapeutics and Century Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Larimar Therapeutics and Century Therapeutics, you can compare the effects of market volatilities on Larimar Therapeutics and Century Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Larimar Therapeutics with a short position of Century Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Larimar Therapeutics and Century Therapeutics.
Diversification Opportunities for Larimar Therapeutics and Century Therapeutics
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Larimar and Century is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Larimar Therapeutics and Century Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Century Therapeutics and Larimar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Larimar Therapeutics are associated (or correlated) with Century Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Century Therapeutics has no effect on the direction of Larimar Therapeutics i.e., Larimar Therapeutics and Century Therapeutics go up and down completely randomly.
Pair Corralation between Larimar Therapeutics and Century Therapeutics
Given the investment horizon of 90 days Larimar Therapeutics is expected to generate 0.95 times more return on investment than Century Therapeutics. However, Larimar Therapeutics is 1.06 times less risky than Century Therapeutics. It trades about -0.04 of its potential returns per unit of risk. Century Therapeutics is currently generating about -0.11 per unit of risk. If you would invest 946.00 in Larimar Therapeutics on July 21, 2024 and sell it today you would lose (170.00) from holding Larimar Therapeutics or give up 17.97% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Larimar Therapeutics vs. Century Therapeutics
Performance |
Timeline |
Larimar Therapeutics |
Century Therapeutics |
Larimar Therapeutics and Century Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Larimar Therapeutics and Century Therapeutics
The main advantage of trading using opposite Larimar Therapeutics and Century Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Larimar Therapeutics position performs unexpectedly, Century Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Century Therapeutics will offset losses from the drop in Century Therapeutics' long position.Larimar Therapeutics vs. KBC Groep NV | Larimar Therapeutics vs. Pfizer Inc | Larimar Therapeutics vs. JPMorgan Chase Co | Larimar Therapeutics vs. Davis Select Worldwide |
Century Therapeutics vs. Edgewise Therapeutics | Century Therapeutics vs. C4 Therapeutics | Century Therapeutics vs. Mineralys Therapeutics, Common | Century Therapeutics vs. Cullinan Oncology LLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |